What are the indications and dosing guidelines for Duloxetine (Cymbalta)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duloxetine (Cymbalta): Indications and Dosing Guidelines

Duloxetine is FDA-approved for five major indications: major depressive disorder in adults, generalized anxiety disorder in adults and pediatric patients 7 years and older, diabetic peripheral neuropathic pain in adults, fibromyalgia in adults, and chronic musculoskeletal pain in adults. 1

FDA-Approved Indications

  • Major Depressive Disorder (MDD): Recommended starting dose is 40-60 mg/day (given as 20 mg twice daily or 60 mg once daily). For some patients, starting at 30 mg once daily for 1 week before increasing to 60 mg once daily may improve tolerability. Maximum effective dose is 60 mg/day. 1

  • Generalized Anxiety Disorder (GAD):

    • Adults <65 years: 60 mg once daily. May start at 30 mg once daily for 1 week before increasing. 1
    • Geriatric patients: 30 mg once daily for 2 weeks before considering increase to 60 mg/day. 1
    • Pediatric patients (7-17 years): 30 mg once daily for 2 weeks before considering increase to 60 mg once daily. Recommended range is 30-60 mg once daily. 1, 2
  • Diabetic Peripheral Neuropathic Pain: 60 mg once daily. No evidence that higher doses provide additional benefit. For patients with tolerability concerns, a lower starting dose may be considered. 1, 3

  • Fibromyalgia: 60 mg once daily. Begin at 30 mg once daily for 1 week before increasing to 60 mg once daily. No evidence that doses above 60 mg/day provide additional benefit. 1, 3

  • Chronic Musculoskeletal Pain (including chronic low back pain and osteoarthritis pain): 60 mg once daily. Begin at 30 mg once daily for 1 week before increasing to 60 mg once daily. 2, 4

Administration Guidelines

  • Take orally with or without food 1
  • Swallow capsules whole - do not chew, crush, or open capsules 1
  • If a dose is missed, take it as soon as remembered unless it's almost time for the next dose 1
  • Do not take two doses at the same time 1

Efficacy Evidence

  • Diabetic Peripheral Neuropathy: Duloxetine 60 mg daily has demonstrated efficacy with a Number Needed to Treat (NNT) of 5 for achieving ≥50% pain reduction at 12 weeks. 5

  • Fibromyalgia: Effective at 60 mg daily with an NNT of 8 for ≥50% pain reduction over 12 weeks. 5, 3

  • Chronic Low Back Pain: Moderate-quality evidence demonstrates small improvements in chronic low back pain. 3

  • Osteoarthritis Pain: Effective particularly in older patients (>65 years) and in patients with knee osteoarthritis. 3

Special Populations and Dosing Considerations

  • Renal Impairment: Consider lower starting dosage and gradual increase for patients with renal impairment, especially for diabetic peripheral neuropathic pain. 1

  • Hepatic Impairment: Use with caution; duloxetine is not recommended for patients with hepatic insufficiency. 6

  • Elderly Patients: Start at lower doses (30 mg once daily) and titrate more slowly. 1

Common Adverse Effects

  • Most common: nausea, dry mouth, headache, constipation, dizziness, and fatigue 2, 7
  • Nausea occurs less frequently if treatment is initiated at 30 mg daily and titrated after one week to 60 mg daily 7
  • Approximately 16% of patients discontinue treatment due to adverse effects 5

Drug Interactions

  • CYP1A2 inhibitors (e.g., fluvoxamine): Can increase duloxetine exposure by up to 460%; concomitant use should be avoided 6

  • CYP2D6 substrates: Duloxetine may increase exposure of drugs metabolized by CYP2D6 6

  • Smoking: Associated with approximately 30% decrease in duloxetine concentration 6

  • MAOIs: Do not use duloxetine with nonselective, irreversible monoamine oxidase inhibitors 7

Discontinuation

  • Duloxetine should be tapered when discontinuing, especially after treatment longer than 3 weeks, to prevent withdrawal symptoms 2

Clinical Pearls

  • For pain conditions, pain relief may begin within one week of treatment at the 60 mg daily dose 7
  • When treating osteoarthritis pain, duloxetine is more effective in older patients (>65 years) than younger patients 3
  • For diabetic neuropathy, duloxetine at 60 mg and 120 mg daily are efficacious, but 20 mg daily is not effective 8
  • Duloxetine may be particularly beneficial for patients with comorbid pain and depression 3

References

Guideline

Duloxetine Scheduling and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.

The Cochrane database of systematic reviews, 2014

Research

[Duloxetine for chronic pain management: pharmacology and clinical use].

Masui. The Japanese journal of anesthesiology, 2013

Research

Duloxetine for treating painful neuropathy or chronic pain.

The Cochrane database of systematic reviews, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.